Clin2
NCT07382167Possibly a fitRecruiting

Study of Tenapanor for Chronic Constipation in Adults

Chronic Idiopathic Constipation (CIC)

Treatments studied

Part of Digestive system clinical trials.

This study tests an investigational drug called tenapanor for people with chronic idiopathic constipation (constipation with no clear cause). It aims to see if the drug can safely improve bowel movements in adults.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
692 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have chronic constipation (not caused by another condition like IBS).
  • You are willing to use birth control if needed, or are not able to have children.
  • You have daily access to a smartphone, tablet, or computer to fill out a diary.
  • You have not had recent stomach or bowel surgery, or a history of certain medical conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05905926Enrolling by invitation· Phase 3
Tenapanor safety study for teens with constipation-predominant IBS

This trial checks the safety of tenapanor in children and teens (ages 6 to under 18) with IBS-C. It is only for people who finished a previous related study and agreed to continue follow-up.

Foley, Alabama
NCT06460038Recruiting· Phase 2
Medication study for constipation in Parkinson's

This study tests whether a medication called tenapanor can help relieve constipation in people with Parkinson's disease. If you have Parkinson's and have been struggling with constipation for at least 6 months, this trial may offer a new option to improve bowel regularity.

Waterloo, Iowa
NCT06736912Not yet recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called IN-114199 in healthy people to see if it is safe and how the body handles it. It is a first-in-human study, meaning it is the first time this drug is given to people.

Seoul
NCT07776119Not yet recruiting
Adding tenapanor to phosphate binders for people on dialysis with high phosphorus

This study tests whether adding a medication called tenapanor (which helps reduce phosphorus absorption in the gut) to your current phosphate binder can improve blood phosphorus levels in people on hemodialysis. It aims to find a safe and effective way to lower phosphorus, which is important for bone and heart health.

Beijing, Beijing Municipality
NCT06832137Not yet recruiting· Phase 1/Phase 2
New medicine for chronic constipation in adults

This trial tests a new medicine called CMTS4520 to help adults with chronic constipation have more regular bowel movements. It aims to see if the medicine is safe and effective for people who have hard, infrequent stools.

Nanjing, Jiangsu
NCT07723924Recruiting· Phase 2
Plecanatide for constipation in children and teens

This study tests a new medicine called plecanatide for children and teens with functional constipation. It aims to see if it helps improve bowel movements compared to a placebo (a pill with no medicine).

Birmingham, Alabama

Hear when a new Chronic Idiopathic Constipation (CIC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.